Showing 9291-9300 of 19220 results for "".
- Advancing Neurosurgical Practices: FDA Approvals and Contemporary Trial Insightshttps://reachmd.com/news/advancing-neurosurgical-practices-fda-approvals-and-contemporary-trial-insights/2485079/The FDA has expanded the indication for TRUFILL n-BCA to permit middl
- Facilitators and Barriers in Mediterranean Diet Adherence: Insights from a Lifestyle Trialhttps://reachmd.com/news/facilitators-and-barriers-in-mediterranean-diet-adherence-insights-from-a-lifestyle-trial/2485083/In a qualitative study of 24 older Spanish adults enrolled in a lifestyle trial of the Mediterranean diet, semi-structured interviews and thematic analysi
- The Kenyan Psoriasis Registry: Early Insights into Clinical Profiles and Treatment Patternshttps://reachmd.com/news/the-kenyan-psoriasis-registry-early-insights-into-clinical-profiles-and-treatment-patterns/2485055/The Kenyan Psoriasis Registry delivers the first systematic, longitudinal dataset on psoriasis in Kenya, offering immediate real‑world evidence to inform screening priorities
- Understanding the Impact of Sex Hormones on Circadian Clocks: Clinical Insightshttps://reachmd.com/news/understanding-the-impact-of-sex-hormones-on-circadian-clocks-clinical-insights/2485052/A recent study indicates that sex hormones can reset cellular circadian clocks via a protein mediator — a finding with potential implications
- Inflammation and Biomarkers: Redefining Cardiovascular Riskhttps://reachmd.com/news/inflammation-and-biomarkers-redefining-cardiovascular-risk/2485057/The American College of Cardiology now endorses screening for C-reactive protein (CRP), elevating inflammatory burden alongside traditional lipid measures in cardiovascular risk assessment. The ACA cited pooled-cohort analyses suggesting that
- Innovative Methods in Assessing Follicular Status: Insights from IVF and Fertility Preservationhttps://reachmd.com/news/innovative-methods-in-assessing-follicular-status-insights-from-ivf-and-fertility-preservation/2485062/A single-center retrospective analysis (n=3,834) found that stopping routine post-GnRH agonist trigger hormone testing did not incre
- Decoding the Brain's Hidden Conversations: Innovations in Glutamate Signal Detectionhttps://reachmd.com/news/decoding-the-brains-hidden-conversations-innovations-in-glutamate-signal-detection/2485063/An engineered protein — the novel glutamate sensor — enhances detection of previously elusive presynaptic glutamate release, enabling direct measurement of neuronal input signals that
- Acne Incidence Higher with Higher-Dose LNG-IUS, Meta-Analysis Findshttps://reachmd.com/news/acne-incidence-higher-with-higher-dose-lng-ius-meta-analysis-finds/2485045/A new systematic review and meta-analysis shows the incidence of acne among users of the levonorgestrel-releasing intrauterine system (LNG-IUS), identifying both dosage and age as influential factors. The review included nine ra
- TALON Study Informs on Brolucizumab vs. Aflibercept in nAMD Treatmenthttps://reachmd.com/news/talon-study-informs-on-brolucizumab-vs-aflibercept-in-namd-treatment/2485056/The TALON study found that brolucizumab supported longer treat‑and‑extend intervals at Week 64 without loss of visual‑acuity efficacy versus aflibercept. The 64‑week trial used an iden
- Emerging Diagnostics: Early Microbiome Changes and Endoscopic Advances in IBDhttps://reachmd.com/news/emerging-diagnostics-early-microbiome-changes-and-endoscopic-advances-in-ibd/2485060/New international data show clear gut microbiome shifts at the onset of inflamma